Search Saint Luke's

For many married couples, dinner is routine: a quiet conversation across the table, the clink of silverware, and the comfort of an ordinary evening. But for Gayle Seward, 71, even sitting through a meal became unbearable due to chest pain.

Megan remembers when her mother was diagnosed with breast cancer—Megan was 6, her mother was in her mid-30s. It seemed too early for both of them to experience that trauma.

After discovering she had an uncommon somatic gene mutation, Laurie Hamilton became determined to help those after her by participating in clinical trials and investing in scientific research for advanced breast cancer.

Sally was working when she felt a pain in her chest so bad it felt like someone punched her.

CHILLICOTHE, Mo.

After dealing with a scary episode and overcoming her own heart issues, Dixie started an effort to educate the women in her life about heart attacks.

Lung Cancer
An Open-Label, Randomized, Controlled Phase 3 Study of Sigvotatug Vedotin in Combination with Pembrolizumab Compared with Pembrolizumab Monotherapy as First-Line Treatment in Participants with PD-L1 High (≥50% of Tumor Cells Expressing PD-L1), Locally Advanced, Unresectable, or Metastatic Non-Small Cell Lung Cancer (SigVie-003). 

After a serious crash in rural Missouri, Mark Carr felt at ease in the hands of the Saint Luke's Hospital of Kansas City trauma team.

Breast Cancer

A Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Camizestrant (AZD9833, a Next Generation, Oral Selective Estrogen Receptor Degrader) vs Standard Endocrine Therapy (Aromatase Inhibitor or Tamoxifen) as Adjuvant Treatment for Patients With ER+/HER2- Early Breast Cancer and an Intermediate-high or High risk of Recurrence Who Have Completed Definitive Locoregional Treatment and Have No Evidence of Disease

A growing body of evidence correlates shorter running sessions to significant health benefits, especially those regarding longevity and mental health.